Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

Documenti analoghi

• Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)
  di: Shapiro, Lauren Q., et al.
  Pubblicazione: (2014)
• Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment
  di: Hu, Ming-Hung, et al.
  Pubblicazione: (2014)
• A Phase II Trial of Bevacizumab + Cetuximab + Cisplatin with Concurrent Intensity Modulated Radiation Therapy (IMRT) for Patients with Stage III/IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
  di: Fury, Matthew G., et al.
  Pubblicazione: (2015)
• Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
  di: Argiris, Athanassios, et al.
  Pubblicazione: (2010)
• Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
  di: Zhou, Xi-Lei, et al.
  Pubblicazione: (2021)